Get the Stockscreener App
30.89
1.10%
0.3369
After Hours:
30.76
-0.1262
-0.41%
Franklin Genomic Advancements Etf stock is traded at $30.89, with a volume of 1,085.
It is up +1.10% in the last 24 hours and up +0.56% over the past month.
See More
Previous Close:
$30.55
Open:
$30.65
24h Volume:
1,085
Relative Volume:
0.43
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+5.63%
1M Performance:
+0.56%
6M Performance:
-2.10%
1Y Performance:
+11.66%
1-Day Range:
$30.65
$30.89
1-Week Range:
$29.19
$30.89
52-Week Range:
$27.54
$33.98
Franklin Genomic Advancements Etf Stock (HELX) Company Profile
Name
Franklin Genomic Advancements Etf
Sector
Industry
Phone
-
Address
-
Compare HELX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HELX
Franklin Genomic Advancements Etf
|
30.89 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
298.20 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
598.83 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
601.82 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
259.72 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
505.30 | 124.43B | 0 | 0 | 0 | 0.00 |
Franklin Genomic Advancements Etf Stock (HELX) Latest News
(HELX) Investment Analysis and Advice - Stock Traders Daily
Trading (HELX) With Integrated Risk Controls - Stock Traders Daily
Trend Tracker for (HELX) - Stock Traders Daily
(HELX) Trading Advice - Stock Traders Daily
(HELX) On The My Stocks Page - Stock Traders Daily
2,250 Shares in CONSOL Energy Inc. (NYSE:CEIX) Purchased by Commonwealth Equity Services LLC - Defense World
(HELX) Technical Data - Stock Traders Daily
Where are the Opportunities in (HELX) - Stock Traders Daily
7 Best-Performing Biotech ETFs for July 2024 - NerdWallet
From AI drones to robots, this fund manager focuses on life-changing technology - MarketWatch
Learn to Evaluate (HELX) using the Charts - Stock Traders Daily
5 Best Performing Biotech ETFs in 2024 - Insider Monkey
ARK reveals the first European Ucits ETFs - RankiaPro En
Franklin Templeton Launches Franklin Focused Growth ETF (FFOG) - Yahoo Finance
12 Best Biotech ETFs To Buy - Yahoo Finance
Revvity (RVTY) Stock Price, News & AnalysisNYSE - MarketBeat
Franklin forges ahead with legal battle over gold ETF - Citywire
Worst performing ETFs this week: Technology ETFs - Trackinsight
Revealed: The best-performing tech managers of Q2 - Citywire Selector
Franklin Templeton launches three thematic funds - Funds Europe Magazine
Technology Could Boost The NPV Of Biopharmaceutical Pipeline Assets Significantly - Seeking Alpha
5 ETFs Riding the Growth Comeback Euphoria - Yahoo Finance
How to Invest in Innovation - International Banker
Recursion Pharmaceuticals (RXRX) Stock Price, News & Analysis - MarketBeat
Robinhood Army Propels Thematic ETFs to a Record-Setting Year - Bloomberg
Franklin Templeton Gives Matt Moberg Three New Funds To Run - Investor's Business Daily
The Year of the Active ETF - Wealth Management
3 Genomics ETFs Worth Jumping For - Benzinga
Investing in Innovation - Wealth Management
Thematic ETFs need careful evaluation… - ETF Express
BioNTech (BNTX) Stock Price, News & Analysis - MarketBeat
Avantor (AVTR) Stock Price, News & Analysis - MarketBeat
Qiagen (QGEN) Stock Price, News & AnalysisNYSE - MarketBeat
Avid Bioservices (CDMO) Stock Price, News & Analysis - MarketBeat
Krystal Biotech (KRYS) Stock Price, News & Analysis - MarketBeat
Voyager Therapeutics (VYGR) Stock Price, News & Analysis - MarketBeat
Natera (NTRA) Stock Price, News & AnalysisNASDAQ - MarketBeat
Ionis Pharmaceuticals (IONS) Stock Price, News & Analysis - MarketBeat
Bio-Rad Laboratories (BIO) Stock Price, News & Analysis - MarketBeat
Bruker (BRKR) Stock Price, News & AnalysisNASDAQ - MarketBeat
Regeneron Pharmaceuticals (REGN) Stock Price, News & Analysis - MarketBeat
Ligand Pharmaceuticals (LGND) Stock Price, News & Analysis - MarketBeat
Vertex Pharmaceuticals (VRTX) Stock Price, News & Analysis - MarketBeat
Franklin Genomic Advancements Etf Stock (HELX) Financials Data
There is no financial data for Franklin Genomic Advancements Etf (HELX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.04%
0.54%
Cap:
|
Volume (24h):